Janssen

Drug Companies Lose Challenge To Alliance Of Private Lawyers And State Officials
Drug Companies Lose Challenge To Alliance Of Private Lawyers And State Officials
Forbes
New Hampshire
Actavis
Endo Pharmaceuticals
Janssen
Purdue Pharma
Teva Pharmaceutical
Flag link:
Janssen gets EU nod for continuous manufacturing
Janssen gets EU nod for continuous manufacturing
BioPharma Dive
Janssen
Europe
drug manufacturing
Prezista
HIV
Flag link:
Ohio attorney general sues 5 pharma companies over their role in the opioid epidemic
Ohio attorney general sues 5 pharma companies over their role in the opioid epidemic
CNBC
Ohio
opioid crisis
opioids
opioid abuse
JNJ
Janssen
Teva Pharmaceutical
Purdue Pharma
Allergan
Endo Health Solutions
Flag link:
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug
Bloomberg
FDA
JNJ
Risperdal
Janssen
Flag link:
FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug Label
FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug Label
RAPS.org
FDA
Janssen
type 2 diabetes
warnings
Invokana
Invokamet
Flag link:
J&J looks for the inside story with new online psoriasis campaign
J&J looks for the inside story with new online psoriasis campaign
Fierce Pharma
JNJ
psoriasis
Janssen
drug marketing
Flag link:
Biotech Renova takes over Janssen's rights to heart failure candidate stresscopin
Biotech Renova takes over Janssen's rights to heart failure candidate stresscopin
Fierce Biotech
Renova Therapeutics
gene therapy
heart failure
Janssen
stresscopin
Flag link:
FDA to withdraw approval of Lannett's generic ADHD drug
FDA to withdraw approval of Lannett's generic ADHD drug
Bizjournals.com
FDA
Lannett
generics
ADHD
Concerta
JNJ
Janssen
Flag link:
Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
Market Realist
JNJ
FDA
type 2 diabetes
diabetes
Invokamet XR
Janssen
Flag link:
GlaxoSmithKline gambles against Gilead with risky bet on two-drug HIV combos
GlaxoSmithKline gambles against Gilead with risky bet on two-drug HIV combos
Fierce Pharma
GSK
Gilead Sciences
HIV
Tivicay
Edurant
Janssen
ViiV
Flag link:
GSK enters $230 million licensing deal with Janssen
GSK enters $230 million licensing deal with Janssen
BioPharma Dive
GSK
Janssen
asthma
Flag link:
J&J's Janssen hit with $70 mln verdict in Risperdal trial
J&J's Janssen hit with $70 mln verdict in Risperdal trial
Yahoo/Reuters
JNJ
Janssen
Risperdal
antipsychotics
Flag link:
FDA warns of kidney risks for diabetes drugs from Janssen, AstraZeneca
FDA warns of kidney risks for diabetes drugs from Janssen, AstraZeneca
BioPharma Dive
FDA
diabetes
Janssen
JNJ
AstraZeneca
Farxiga
Invokana
Flag link:
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
Fierce Pharma
JNJ
Invokana
type 1 diabetes
Janssen
Flag link:
Janssen's multiple myeloma drug passes muster in Europe
Janssen's multiple myeloma drug passes muster in Europe
BioPharma Dive
Janssen
Multiple Myeloma
Europe
JNJ
Darazalex
Flag link:
MacroGenics scores drug licensing deal worth up to $740 million
MacroGenics scores drug licensing deal worth up to $740 million
Bizjournals.com
Macrogenics
Janssen
MGD015
cancer immunotherapy
Flag link:
Updated survival data added to Imbruvica's label
Updated survival data added to Imbruvica's label
BioPharma Dive
Imbruvica
CLL
Janssen
Flag link:
Why ViiV Healthcare leads the pharma industry in corporate reputation
Why ViiV Healthcare leads the pharma industry in corporate reputation
BioPharma Dive
ViiV Healthcare
Pfizer
GSK
Shionogi
AbbVie
Lundbeck
Janssen
Novo Nordisk
Flag link:
Novartis' Cosentyx proves superior to Janssen's Stelara in head-to-head comparison
Novartis' Cosentyx proves superior to Janssen's Stelara in head-to-head comparison
BioPharma Dive
Novartis
Cosentyx
Janssen
Stelara
psoriasis
Flag link:
Biosimilars Are Coming After Big Pharma's Bottom Line
Biosimilars Are Coming After Big Pharma's Bottom Line
Fortune
Big Pharma
biosimilars
Roche
AbbVie
MabThera
Herceptin
Avastin
Humira
Janssen
Remicade
Flag link: